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Abstract The aim of the present study was to evaluate long-term efficacy of a patient education programme in an
asthma out-patient clinic.The study included two groups. Educational group consisted of 25 patients who were given
special education for one year.Usual care group included 27 patientswhowere not given special education. All patients
wereevaluatedafter 3 years follow-upperiod.Meanpercentasthmaknowledge score (KS%),meanpercentdemonstra-
tion score (DS%), daytime andnighttime symptomscores,Aas score, andpulmonary functiontestsweremeasured.The
asthma-quality-of-life assessmentwas performed.The rate of application to emergencyroomand admission to hospital
forlast1yearhadbeencalculated.KS%washigherineducationalgroupthaninusualcaregroup (Po0.001).Daytime score
was 0.370.6 in educationalgroup andwas 0.871.2 inusual care group (P=0.08).Nighttime symptom scorewas found to
be 0.570.9 and 0.971.3, respectively (P=0.07).Usual care group had higher Aas score compared to educational group
(P=0.048).The total score of quality of life was 197.1717.8 in educational group and was 176.7733.7 in usual care group
(P=0.009).Whilenoneofthepatientshademergencyroomapplication andhospital admissionineducationalgroup, seven
patients had 21emergency room application (P=0.01) and four patients had four hospital admissions in usual care group.
Additional short-acting inhaled beta-2 agonist usagewas found lower in the educational group (P=0.068). In conclusion,
proper drug use and usual care of patients are not sufficient for asthma treatment. Patient education is an important
componentof therapy in asthma patients.For a lifewith optimum standards, in addition to these factors, patient educa-
tionmust be accepted first bydoctors and thenbypatients.r2002 Publishedby Elsevier Science Ltd
doi:10.1053/rmed.2001.1309, available online athttp://www.idealibrary.comon
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Asthma is a major public health problem worldwide. It
a¡ects between 7 and 20 million people in the United
States, depending on the de¢nition, 2^5 million of whom
are children (1,2). Asthma and related health problems
utilize a signi¢cant percentage of health-care budget in
most developed countries (3,4).The direct cost of asth-
ma was estimated to be 6.2 billions per year in the Uni-
ted States, and the indirect cost related to reduced
productivity caused by absenteeism at school or work
was calculated to be 1billion per year (4). Asthma mor-
bidity and mortality have been increasing, despite more
knowledge about the in£ammatory process involved in
asthmatic airways, followed by the development of new
drugs (2,5).
A signi¢cant number of asthma deaths are thought to
bepreventable (6). It has beenreported thatpatient edu-
cation can reduce morbidity and mortality, health-careReceived 30October 2001, accepted in revised form 21January 2002.
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(5,7^10).The International Consensus Report onDiagno-
sis and Management of Asthma (11) concluded in its
guidelines that educationwas one of the critical compo-
nents of asthma treatment.The aim of the present study
was to evaluate long-term e¡ects of patient education in
asthmatic patients.
METHODS
The present study was conducted at a tertiary care hos-
pital in Istanbul, Turkey. Informed consent was obtained
from all patients.
Subjects and randomization
The study included eligible adult asthmatic patients who
were followed in out-patient clinic.They were diagnosed
as having asthma by a chest physician and asthma was
their primary problem, were over the age of 16 years,
were literate and capable of completing questionnaires
in Turkish, intended to reside in Istanbul during the 3
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FIG. 1. Studydesign for randomization.
TABLE 1. Demographic and baseline characteristics of
the groups
Educational
groupa
Usual care
groupa
Female 15 19
Male 10 8
Total 25 27
Mean age 30.6
(range,17^52)
28.9
(range,16^51)
Meanduration of
disease (years)
8.1 8.3
Education level
Primary school 12 14
High school 10 11
University 3 2
Diagnosis
Asthma 11 12
Asthma plus rhinitis 14 15
Severityof asthma
Mild 10 10
Moderate 12 13
Severe 3 4
Baseline values: mean (SD)
FEV1% 69.3 (17.5) 68.4 (19.8)
Daytime symptom score 1.1 (0.7) 1.1 (0.9)
Nighttime symptom score 1.1 (0.9) 1.2 (1.0)
aP40.05.
520 RESPIRATORYMEDICINEyears study period, and had a recorded address and
phone number.The diagnosis of asthmawas based on in-
ternationally accepted guidelines (11). The patients with
hearing or sightproblems and thosewho could not com-
municate, read and write inTurkish adequately were ex-
cluded from the study. A total of 80 patients who agreed
to participate in the study were allocated to either edu-
cational (n=40) or usual care (n=40) groups. Figure 1
shows the study design for randomization.Twenty-eight
patients dropped out of the study. Educational group in-cluded 25 subjects with asthma. Usual care group con-
sisted of 27 subjects with asthma. Table 1 summarizes
the baseline characteristics of two groups. There were
no signi¢cant di¡erences between educational and usual
care groups at baseline.
Study design
The educational group attended the programme regu-
larly for a period of12months.This groupwas scheduled
for a bimonthly visit at an out-patient clinic for12months
due to six patient education seminars. Later, this group
was followed-up like the usual care group in the asthma
out-patient clinic.The education programme included in-
formation about the concept of asthma and its manage-
ment. The information covered signs and symptoms of
asthma and asthma exacerbations, triggering factors,
somenotions onrelief and onpreventive asthmamedica-
tions, and training in the inhalation technique. Education
was given by a chest physician with experience in coun-
selling and teaching asthma patients.The education pro-
grammewas as follows: (1) Video cassettes were shown
in out-patient clinic. (2) A specially constructed patient
brochurewas given. (3) Patient education seminars were
given six times by a chest physician. (4) Inhalation device
usage technique was checked in each visit and if impro-
per usage technique was determined corrections in
usage techniqueweremadeby a chestphysician. (5) Tele-
phone helplines were provided to patients during educa-
tion programme.The usual care groupwas submitted to
the routine care provided at the asthma out-patient
clinic, with no formal instruction regarding asthma and
itsmanagement.
Outcomemeasures
All patients were evaluated at the study day after a 3
years follow-up period. An asthma knowledge question-
ASTHMAEDUCATIONPROGRAMME 521naire including 20 questions was ¢lled to assess patients’
knowledge about asthma and percent knowledge score
was calculated.Percentknowledge scorewas formulated
as follows: (number of correct answers/number of total
questions) 100. Inhalation device usage techniques
were evaluated in several steps and percent demonstra-
tion score was calculated. Percent demonstration score
was formulated as follows: (number of correct steps/
number of total steps) 100. Daytime and night time
scoreswereused to assess severityof asthma for the last
month. Daytime and nighttime symptom scores were
measured according to a scoring system (12).The sever-
ity of disease for the last year was measured by Aas
score. Asthma severity was scored from 1 to 5 by Aas
score (13).The asthma-quality-of-life questionnairebased
on article by Juniper et al. (14) was used to assess the
quality of life.The rate of application to emergency room
and admission to hospital for the last year were mea-
sured in each patient. Additional short-acting inhaled
b2-agonist usagewas analysed for the lastmonth.
Statistical analysis
Thegroupswere comparedwith chi-square and Student-
t tests.The results were comparedwith Mann^Whitney
U test, Fischer exact test and chi-square test between
two groups and were compared with Wilcoxon test
within group.
RESULTS
Table 2 demonstrates FEV1 values of the two groups.
Asthma therapy improved FEV1 values of the groups at
the end of 3 years. This improvement was more signi¢-
cant in the educational group than in the usual care
group, but therewasno statistically signi¢cant di¡erence
between the two groups with respect to per cent FEV1
values at the end of 3 years.
Daytime, nighttime, and Aas scores of two groups are
summarized inTable 3.While daytime scores were signif-
icantly reduced in educational group (P=0.0002), thereTABLE 2. The FEV1values ofthe groups
Educationalgroup
Baseline After 3 ye
Mean 69.3a 84.9a
SD 17.5 18.7
Median 69.0 90.1
95% CI 62.1^76.6 77.2^92.6
aP=0.0002.
bP=0.002was no signi¢cant change in usual care group at the end
of 3 years compared to baseline values (P40.05). There
was a slight di¡erence between the two groups with re-
spect to daytime scores at the end of 3 years (P=0.08).
The therapy produced a signi¢cant reduction in night-
time scores in educational group (P=0.0025) and in usual
care group (p=0.021).Nighttime scorewas slightly higher
in usual care group than in educational group at the end
of 3 years (P=0.07). Educational group had lower Aas
score compared to usual care group (P=0.048).
The asthma-quality-of-life scorewas197.1717.8 in edu-
cational group and 176.7733.7 in usual care group
(P=0.009).Table 4 showsper centknowledge and demon-
stration scores of the groups. Educational group had
higher mean per cent knowledge score compared to
usual care group (Po0.001).There was no signi¢cant dif-
ference inbetween two groupswithrespect tomeanper
cent demonstration score (P40.05).
In educational group, therewere 22 patients receiving
additional short-acting inhaled b2-agonist for the last
month before the intervention. Four patients received
additional short-acting inhaled b2-agonist for the last
month at the end of 3 years (Po0.0001). In usual care
group, while there were 24 patients receiving additional
short-acting inhaled b2-agonist before the intervention,
there were 11 patients receiving additional short-acting
inhaled b2-agonist at the end of 3 years (P=0.0004). Ac-
cording to the number of patients receiving additional
short-acting inhaled b2-agonist, there was no signi¢cant
di¡erence between the two groups before the interven-
tion. The number of patients receiving additional short-
acting inhaled b2-agonist was slightly higher in usual care
group than in educational group at the end of 3 years
(P=0.068).Table 5 shows amount of additional short-act-
ing inhaled b2-agonist. Although amount of additional
short-acting inhaled b2-agonist was higher in usual care
group compared to educational group there was no sig-
ni¢cant di¡erence between the two groups at the end of
3 years (P40.05).
Before the intervention, 17 patients in educational
group had 58 emergency room applications for the last
year.The mean number of the applications was 2.3 (95%Usual care group
ars Baseline After 3 years
68.4b 77.6b
19.8 18.5
71.0 78.0
60.6^76.2 70.3^84.9
TABLE 3. Daytime, nighttime and Aas scores of the groups
Daytime score Nighttime score Aas score
Baseline After 3 years Baseline After 3 years After 3 years
Educational Group
Mean 1.1a 0.3 1.1b 0.5 1.2c
SD 0.7 0.6 0.9 0.9 0.4
Median 1.0 0.0 1.0 0.0 1.0
95% CI 0.8^1.4 0.1^0.6 0.7^1.5 0.1^0.9 1.0^1.3
Usual care group
Mean 1.1a 0.8 1.2b 0.9 1.7c
SD 0.9 1.2 1.0 1.3 0.9
Median 1.0 0.0 1.1 0.0 1.0
95% CI 0.8^1.5 0.3^1.3 0.9^1.6 0.4^1.4 1.3^2.0
aP40.05.
bP40.05.
cP=0.048.
TABLE 4. The per cent knowledge and demonstration
scores of the groups
Educational
group
Usual
care group
Percentknowledge score
Mean 77.6a 53.8a
SD 12.0 14.6
Median 80.0 55
95% CI 69.3^81.1 50.5^62.1
Percent Demonstration Score
Mean 97.4b 92.9b
SD 6.1 15.6
Median 100 100
95% CI 94.8^99.7 86.6^98.9
aPo0.001.
bP40.05.
522 RESPIRATORYMEDICINECI, 0.7^3.9) in this group. In usual care group,18 patients
had 57 emergency room applications for the last year.
The mean number of the applications was 2.1 (95% CI,
0.7^3.5) in the usual care group. According to the num-
ber of emergency room applications, therewas no signif-
icant di¡erence between two groups before the
intervention (P40.05). After the intervention, while
none of the patients had emergency room application in
educational group, 7 patients had 21emergencyroom ap-
plications in usual care group (P=0.01).
In educational group, 8 patients had14 hospital admis-
sions for the last year before the intervention.Themean
number of hospital admission was 0.6 (95% CI, 0.1^1.0).
None of the educational patients hadhospital admissions
at the end of 3 years. In usual care group,10 patients had
15 hospital admissions for the last year before the inter-
vention.Themean number of hospital admissionswas 0.6(95% CI, 0.2^0.9). Four patients had four hospital admis-
sions at the end of 3 years in this group (P40.05). Before
the intervention, there was no signi¢cant di¡erence be-
tween two groups with respect to the number of hospi-
tal admissions (P40.05). Although the reduction in the
number of hospital admissions was more signi¢cant in
educational group compared to usual care group, there
was no signi¢cant di¡erence between two groups at the
end of 3 years (P40.05).
DISCUSSION
The present study assessed the e¡ectiveness of an asth-
ma education programme on asthma patients attending
our out-patientclinic.This studyevaluatedoutcomemea-
sures such asper centknowledge score, per cent demon-
stration score, FEV1 value, daytime and nighttime
symptom scores, Aas score, the asthma-quality-of-life
assessment, the rate of application to emergency room
and admission to hospital and additional short-acting in-
haled b2-agonist usage in educational and usual care
groups.
We found that our education programme produced
signi¢cant improvements in clinical and functional mea-
sures of asthmatic patients, with a reduction in health
service utilization and asthma morbidity. We observed
partial clinical and functional improvements in usual care
groups. FEV1 values increased in both groups. This in-
crease was more signi¢cant in educational group com-
pared to usual care group, but there was no statistically
signi¢cant di¡erence between the two groups with re-
spect to per cent FEV1values at the end of 3 years. Many
studies reported that education programmes resulted in
an increase in FEV1and PEF values (15^17).However, not
all studies have found a signi¢cant e¡ect on lung
TABLE 5. Thenumberofmonthlydosages of short-acting inhaled b2-agonist
Educationalgroup Usual care group
Baseline After 3 years Baseline After 3 years
Mean 57.7 5.3 57.9 15.7
SD 57.7 16.6 55.9 31.1
Median 30.0 0.0 60.0 0.0
95% CI 33.9^81.5 1.5^12.1 35.8^80.0 3.3^28.0
ASTHMAEDUCATIONPROGRAMME 523functions after education programme (9,18). Severity of
asthma for the last month was assessed by daytime and
nighttime symptom scores in the present study. While
daytime scores were signi¢cantly reduced in educational
group, nighttime scores were decreased in both groups.
Aas score was used to assess severity of asthma for the
last year. Aas score was lower in the educated group
than in usual care group. de Oliveira et al. (9) reported
that an educational programme reduced nocturnal and
diurnal symptoms. The data of Gallefoss et al. (15) sup-
ported these results. They revealed better symptoms
and activity after patient education. In educated group,
the improvement in pulmonary function tests and the
reduction in symptom scores and Aas score were asso-
ciated with better quality-of-life assessment in our ser-
ies. It is known that education programmes improve
quality-of-life scores (10,15). All improvements may be
due to a variety of factors such as acquisition of knowl-
edge, compliance with therapy, and receiving more at-
tention from the medical team (9,19). Our results
suggested that educated patients had higher asthma
knowledge score compared to usual care patients.There
was no signi¢cant di¡erence between two groups with
respect to inhalation device usage technique because
usual care patients like educated patients were trained
to use correct inhalation technique. According to our
opinion, increased asthma knowledge, increased patient
compliance and receivingmore attention from themedi-
cal team are causes of improvements in outcome mea-
surements.
Improvements in outcomemeasures such as symptom
scores, Aas score, quality-of-life assessment andpulmon-
ary function tests result in reductions in asthmamorbid-
ity andmortality (7,10,20,21).Choyetal. (7) reported that
an education programme resulted in reductions in the
numbers of hospitalizations, visits to physicians and
emergencydepartment attendance during the studyper-
iod. A previous report suggested that patient education
may reduce the amount of short-acting inhaled b2-ago-
nists (19).We found that the therapy reduced emergency
room application and the amountof additional short-act-
ing inhaled b2-agonists. Improvements in these outcome
measures were more signi¢cant in educational group
than in usual care group.In conclusion, proper drug use and usual care of pa-
tients are not su⁄cient for asthma treatment. Our re-
sults suggest that an asthma education programme in
an out-patient clinic has a positive impact on asthma
morbidity and it is an important component of therapy
in asthma patients. For a life with optimum standards, in
addition to these factors patient education must be ac-
cepted ¢rst by doctors and then by patients.
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